RTI wins FDA nod for device used in soft tissue repair

03/14/2013 | RTT News

The FDA has given RTI Biologics 510(k) clearance to market its porcine dermis implantable device, which is intended for use in hernia repair and other soft tissue fixation procedures. The device, slated for U.S. distribution later this year, serves as a scaffold that can be used for neovascularization or that can be reincorporated with the patient's own tissue.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA